Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQHealth CareAsset Management - CryptocurrencySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
2.42 → 2.42 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for HYPD yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Permanent CEO appointed and stabilizes leadership | The new CEO was appointed in early 2026. | Intact | CEO departs or leadership becomes unstable | CEO stable (qualitative) July 2026 officer change event notes new employment agreements for CEO, CFO, and General Counsel to ensure consistency. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, speculative growth business with exposure to the Healthcare sector and DeFi activities. Its long-term thesis is intact: recent financial performance is strong, but the company remains loss-making and management has been volatile.
HYPD is expensive versus peers, with a 5.59 premium measure, though confidence in the valuation model is low. The evidence points to optionality as the main source of valuation divergence, but does not specify exactly what growth the market assumes.
Near term, management’s focus on Adjusted Gross Profit and DeFi operations is showing progress, with sequential growth and higher 2026 guidance. HYPE token deployment and staking income have also grown, while HAUS partnerships are newer and have mixed evidence so far. Recent earnings beats are positive, but small-cap status and erratic earnings surprises leave some risk of a miss or a guidance cut.
The multi-year view depends on continued growth in Adjusted Gross Profit, DeFi operations, and income from token deployment, alongside progress in HAUS partnerships. Near term, a guidance cut would be a negative, while weakening jobs data could weigh on cyclical Healthcare names. Continued earnings strength from sector bellwether SDEV would support sector momentum.
Over the next 1 to 3 years, the thesis rests on turning strong recent operating growth into durable business progress while managing loss-making results and execution risks. The valuation is expensive versus peers, and the evidence on what is priced in is limited. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Hyperion DeFi plans to stop supporting USDH stablecoin. |
| Intact |
| USDH support continues beyond 2026 |
Transition initiated May 2026 vs End-2026 target May 2026 disclosure confirms USDH support ceased and conversion to USDC encouraged, meeting the 2026 transition target. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches about $6 million in 2026 | A primary condition in HYPERION DEFI INC's published investment case. The stated target is ~$6 million. | Intact | Revenue falls below $4.75 million in FY26 | Revenue: $357,693 FY2026-Q2; GAAP. Published target: ~$6 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 12, 2026357,693 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.43 → $2.42 · observed estimates
$0.02B → $0.02B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-07-25 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-07-26 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-07-27 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-07-28 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-07-29 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-07-30 | $0.43 | $2,369,500 | 2 / 2 |
| 2026-07-31 | $0.43 | $2,369,500 | 2 / 2 |
| 2026-08-01 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-02 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-03 | $0.43 | $2,369,500 | 2 / 2 |
| 2026-08-04 | $0.43 | $2,369,500 | 2 / 2 |
| 2026-08-05 | $0.43 | $2,369,500 | 2 / 2 |
| 2026-08-06 | $0.43 | $2,369,500 | 2 / 2 |
| 2026-08-07 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-08 | $0.43 | $2,369,500 | 2 / 2 |
| 2026-08-09 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-10 | $0.43 | $2,369,500 | 2 / 2 |
| 2026-08-12 | $0.43 | $2,369,500 | 2 / 2 |
| 2026-08-13 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-14 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-15 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-16 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-17 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-18 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-19 | $0.43 | $15,579,667 | 1 / 1 |
| 2026-08-20 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-21 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-22 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-23 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-24 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-25 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-26 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-27 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-28 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-29 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-30 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-08-31 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-09-01 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-09-02 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-09-03 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-09-04 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-09-05 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-09-06 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-09-07 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-09-08 | $1.21 | $16,007,667 | 1 / 1 |
| 2026-09-09 | $1.17 | $16,399,999 | 1 / 1 |
| 2026-09-10 | $1.17 | $16,399,999 | 1 / 1 |
| 2026-09-11 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-12 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-13 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-14 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-15 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-16 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-17 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-18 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-19 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-20 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-21 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-22 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-23 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-24 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-25 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-26 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-27 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-28 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-29 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-09-30 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-01 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-02 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-03 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-04 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-05 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-06 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-07 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-08 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-09 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-10 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-11 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-12 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-13 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-14 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-15 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-16 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-17 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-18 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-19 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-20 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-21 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-22 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-23 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-24 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-25 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-26 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-27 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-28 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-29 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-30 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-10-31 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-11-01 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-11-02 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-11-03 | $2.42 | $17,833,333 | 1 / 1 |
| 2026-11-04 | $2.42 | $17,833,333 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
1 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.